Dental Anesthesia Companies

Top Industry Leaders in the Dental Anesthesia Market

Dental Anesthesia Key Companies Disclaimer: List of key companies in no particular orderLatest Dental anesthesia Companies Update

May 2023: The leading sterile injectable contract manufacturing and development organization (CDMO) in Ontario, Novocol Pharma, has entered into a long-term agreement with Moderna, Inc., a biotechnology company that pioneered messenger RNA (mRNA) therapeutics and vaccines, to perform aseptic fill-finish, labeling, and packaging of mRNA respiratory vaccines anticipated to be produced in Canada. The last stage of the production cycle, known as fill-finish sterile manufacturing, entails putting the vaccine medication product into vials and preparing it for use. The deal with Novocol Pharma will increase the fill-finish capacity of vaccines produced at Moderna's mRNA facility in Laval. Subject to planning and regulatory permissions, the facility is anticipated to open for business by the end of 2024.

Aug 2023: For a purchase price of $70 million, subject to closing and other changes, 3M stated that it had finalized the sale of some assets from its dentistry local anesthetic portfolio, based in Germany, to Pierrel S.p.A. ("Pierrel"), a worldwide provider of services for the pharmaceutical sector. These local anesthetic items, which are mostly sold in Europe and Asia, comprise related syringe and needle products as well as goods sold under the trademarks UbistesinTM, XylestesinTM, and MepivastesinTM. These were previously a component of 3M's Oral Care Solutions Division's dental materials business. 3M decided to discontinue these products as part of its continuing strategic portfolio management and to give priority to initiatives that make use of the fundamental oral care technologies of its Health Care business.

List of Dental anesthesia Key companies in the market